Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
4.120
+0.120 (3.00%)
At close: Jun 26, 2026, 4:00 PM EDT
4.050
-0.070 (-1.70%)
After-hours: Jun 26, 2026, 4:45 PM EDT
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $231.56 million as of June 26, 2026. Its market cap has increased by 82.43% in one year.
Market Cap
231.56M
Enterprise Value
54.38M
1-Year Change
82.43%
Ranking
Category
Stock Price
$4.12
Market Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from $173.16M to $231.56M, an increase of 33.73%. That is a compound annual growth rate of 4.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 231.56M | -18.93% |
| Dec 31, 2025 | 285.62M | 12.67% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sol-Gel Technologies | 237.56M |
| Foghorn Therapeutics | 236.62M |
| Orchestra BioMed Holdings | 233.53M |
| Anavex Life Sciences | 228.44M |
| Coherus Oncology | 228.29M |
| Whitehawk Therapeutics | 222.66M |
| Unicycive Therapeutics | 219.21M |
| Atrium Therapeutics | 218.61M |